Suchergebnisse - "Ramkumar, Kavya"

PubPharm (39)

1

YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities

enthalten in: bioRxiv.org | 2023

von Stewart, C. | Diao, L. | Xi, Y. | +25

2

Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Ramkumar, K. | Tanimoto, A. | Della Corte, C. | +14

CommentIn: Transl Lung Cancer Res. 2024 Feb 29;13(2):223-228. - PMID 38496702

3

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

enthalten in: Journal of translational medicine | 2022

von Della Corte, C. | Ciaramella, V. | Ramkumar, K. | +19

4

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

enthalten in: Journal of translational medicine | 2022

von Della Corte, C. | Ciaramella, V. | Ramkumar, K. | +19

5

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

enthalten in: Journal of translational medicine | 2022

von Della Corte, C. | Ciaramella, V. | Ramkumar, K. | +19

6

Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation : findings from the CAVE-Lung trial

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Della Corte, C. | Fasano, M. | Ciaramella, V. | +18

7

Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

enthalten in: Journal of experimental & clinical cancer research | 2022

von Della Corte, C. | Fasano, M. | Ciaramella, V. | +18

8

Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

enthalten in: Journal of experimental & clinical cancer research | 2022

von Della Corte, C. | Fasano, M. | Ciaramella, V. | +18

9

Anti-tumor Activity of Cetuximab Plus Avelumab in Non-Small Cell Lung Cancer Patients Involves Innate Immunity Activation: Findings from the CAVE-Lung Trial

enthalten in: ResearchSquare.com | 2022

von Corte, C. | Fasano, M. | Ciaramella, V. | +18

10

A wake-up call for cancer DNA damage : the role of Schlafen 11 (SLFN11) across multiple cancers

enthalten in: British journal of cancer | 2021

von Zhang, B. | Ramkumar, K. | Cardnell, R. | +6